Our Head of Medical & Science, Vincent Brechin, Ph.D., is gearing up for his Keynote Speech at the NOAR Europe Annual Meeting in Nantes! 

Catch his presentation on: “The economic aspects linked to Nuclear Medicine with a focus on the current craze for alpha therapy”

 When: Tuesday, November 4th, 2025
 Where: NOAR Europe Annual Meeting (Nov 3-5, 2025), Nantes

Combining his expertise as a Medical Scientist with hands-on experience at NucAdvisor / MEDraysintell, Dr Brechin will deliver an insightful talk on the evolving field of nuclear medicine. He will provide a comprehensive overview of the global nuclear medicine market and highlight the emerging role of Astatine-211 and other Alpha emitters in a landscape currently dominated by Beta emitters such as Pluvicto or Lutathera.

This session is essential for anyone seeking to understand the market dynamics driving the Alpha therapy boom.
If you’re at the meeting, be sure to check out his session!

Event details : https://astatine-net.eu/news/noar-europe-annual-meeting-from-3-to-5-november-2025-in-nantes/